No. | Publication Date | Citing Article |
---|---|---|
1 | 2024 | Hannah Thurgur, Michael Lynskey, Anne Katrin Schlag, Carol Croser, David John Nutt, Elizabeth Iveson. Feasibility of a cannabidiol‐dominant cannabis‐based medicinal product for the treatment of long COVID symptoms: A single‐arm open‐label feasibility trial, British Journal of Clinical Pharmacology. 2024;90:1081. https://doi.org/10.1111/bcp.15988 |